{"data":{"id":"us-ok/okla.-stat.-tit.-63-63-2-208","jurisdiction":"us-ok","citation":"Okla. Stat. tit. 63, § 63-2-208","heading":"Schedule III","body":"The controlled substances listed in this section are included in\n\nSchedule III.\n\nA. Unless listed in another schedule, any material, compound,\n\nmixture, or preparation, which contains any quantity of the\n\nfollowing substances or any other substance having a potential for\n\nabuse associated with a stimulant or depressant effect on the\n\ncentral nervous system:\n\n1. Any drug product containing gamma-hydroxybutyric acid,\n\nincluding its salts, isomers, and salts of isomers, for which an\n\napplication has been approved under Section 505 of the Federal Food,\n\nDrug, and Cosmetic Act;\n\n2. Any material, compound, mixture, or preparation which\n\ncontains any quantity of the following hormonal substances or\n\nsteroids, including their salts, isomers, esters and salts of\n\nisomers and esters, when the existence of these salts, isomers,\n\nesters, and salts of isomers and esters is possible within the\n\nspecific chemical designation:\n\na. Boldenone,\n\nb. Chlorotestosterone,\n\nc. Clostebol,\n\nd. Dehydrochlormethyltestosterone,\n\ne. Dihydrotestosterone,\n\nf. Drostanolone,\n\ng. Ethylestrenol,\n\nh. Fluoxymesterone,\n\ni. Formebolone,\n\nj. Mesterolone,\n\nk. Methandienone,\n\nl. Methandranone,\n\nm. Methandriol,\n\nn. Methandrostenolone,\n\no. Methenolone,\n\np. Methyltestosterone, except as provided in subsection E\n\nof this section,\n\nq. Mibolerone,\n\nr. Nandrolone,\n\ns. Norethandrolone,\n\nt. Oxandrolone,\n\nu. Oxymesterone,\n\nv. Oxymetholone,\n\nw. Stanolone,\n\nx. Stanozolol,\n\ny. Testolactone,\n\nz. Testosterone, except as provided in subsection E of\n\nthis section, and\n\naa. Trenbolone;\n\n3. Any substance which contains any quantity of a derivative of\n\nbarbituric acid, or any salt of a derivative of barbituric acid;\n\n4. Benzephetamine and its salts;\n\n5. Buprenorphine;\n\n6. Butalbital/acetaminophen/caffeine;\n\n7. Chlorhexadol;\n\n8. Chlorphentermine and its salts;\n\n9. Clortermine;\n\n10. Glutethimide;\n\n11. Ketamine, its salts, isomers, and salts of isomers;\n\n12. Lysergic acid;\n\n13. Lysergic acid amide;\n\n14. Mazindol;\n\n15. Methyprylon;\n\n16. Phendimetrazine;\n\n17. Phenylacetone (P2P);\n\n18. Sulfondiethylmethane;\n\n19. Sulfonethylmethane;\n\n20. Sulfonmethane;\n\n21. Tetrahydrocannibinols;\n\n22. 1-Phenycyclohexylamine; or\n\n23. 1-Piperidinocychexanecarbo nitrile (PCC).\n\nLivestock implants as regulated by the Federal Food and Drug\n\nAdministration shall be exempt.\n\nB. Nalorphine.\n\nC. Unless listed in another schedule, any material, compound,\n\nmixture, or preparation containing limited quantities of any of the\n\nfollowing narcotic drugs, or any salts thereof:\n\n1. Not more than one and eight-tenths (1.8) grams of codeine or\n\nany of its salts, per one hundred (100) milliliters or not more than\n\nninety (90) milligrams per dosage unit, with an equal or greater\n\nquantity of an isoquinoline alkaloid of opium;\n\n2. Not more than one and eight-tenths (1.8) grams of codeine or\n\nany of its salts, per one hundred (100) milliliters or not more than\n\nninety (90) milligrams per dosage unit, with one or more active,\n\nnonnarcotic ingredients in recognized therapeutic amounts;\n\n3. Not more than one and eight-tenths (1.8) grams of\n\ndihydrocodeine or any of its salts, per one hundred (100)\n\nmilliliters or not more than ninety (90) milligrams per dosage unit,\n\nwith one or more active, nonnarcotic ingredients in recognized\n\ntherapeutic amounts;\n\n4. Not more than three hundred (300) milligrams of\n\nethylmorphine or any of its salts, per one hundred (100) milliliters\n\nor not more than fifteen (15) milligrams per dosage unit, with one\n\nor more ingredients in recognized therapeutic amounts;\n\n5. Not more than five hundred (500) milligrams of opium per one\n\nhundred (100) milliliters or per one hundred (100) grams, or not\n\nmore than twenty-five (25) milligrams per dosage unit, with one or\n\nmore active, nonnarcotic ingredients in recognized therapeutic\n\namounts; or\nor not more than fifteen (15) milligrams per dosage unit, with one\n\nor more ingredients in recognized therapeutic amounts;\n\n5. Not more than five hundred (500) milligrams of opium per one\n\nhundred (100) milliliters or per one hundred (100) grams, or not\n\nmore than twenty-five (25) milligrams per dosage unit, with one or\n\nmore active, nonnarcotic ingredients in recognized therapeutic\n\namounts; or\n\n6. Not more than fifty (50) milligrams of morphine or any of\n\nits salts, per one hundred (100) milliliters or per one hundred\n\n(100) grams with one or more active, nonnarcotic ingredients in\n\nrecognized therapeutic amounts.\n\nD. The Board of Pharmacy may except by rule any compound,\n\nmixture, or preparation containing any stimulant or depressant\n\nsubstance listed in subsections A and B of this section from the\n\napplication of all or any part of the Uniform Controlled Dangerous\n\nSubstances Act if the compound, mixture, or preparation contains one\n\nor more active medicinal ingredients not having a stimulant or\n\ndepressant effect on the central nervous system, and if the\n\nadmixtures are included therein in combinations, quantity,\n\nproportion, or concentration that vitiate the potential for abuse of\n\nthe substances which have a stimulant or depressant effect on the\n\ncentral nervous system.\n\nE. The following hormonal substances or steroids are exempt\n\nfrom classification as Schedule III controlled dangerous substances:\n\n1. Estratest, containing 1.25 mg esterified estrogens and 2.5\n\nmg methyltestosterone;\n\n2. Estratest HS, containing 0.625 mg esterified estrogens and\n\n1.25 mg methyltestosterone;\n\n3. Premarin with Methyltestosterone, containing 1.25 mg\n\nconjugated estrogens and 10.0 mg methyltestosterone;\n\n4. Premarin with Methyltestosterone, containing 0.625 mg\n\nconjugated estrogens and 5.0 mg methyltestosterone;\n\n5. Testosterone Cypionate - Estrodiol Cypionate injection,\n\ncontaining 50 mg/ml Testosterone Cypionate; and\n\n6. Testosterone Enanthate - Estradiol Valerate injection,\n\ncontaining 90 mg/ml Testosterone Enanthate and 4 mg/ml Estradiol\n\nValerate.","path":["OK Code","Title 63"],"source_url":"https://www.oklegislature.gov/OK_Statutes/CompleteTitles/os63.pdf","current_through":"2026-08-14","vintage":"open-us-law v2026.08, retrieved 2026-09-14","retrieved_at":"2026-09-14T18:32:36Z","sha256":"9a932ff0465e945a2f2a46d5f545e6b9a424af680782944afa9324cf1a062380","source_id":"us-ok","stale":false,"prev":"us-ok/okla.-stat.-tit.-63-63-2-207","next":"us-ok/okla.-stat.-tit.-63-63-2-209"},"notice":"GroundRules: Original legal text. Not legal advice."}